August 2025 FDA Recall Enoxaparin Sodium by Cardinal Health Inc.
D-0597-2025 - Correct Labeled Product Mispack

This Class II drug recall was voluntarily initiated by Cardinal Health Inc. on August 5, 2025 for the product Enoxaparin Sodium. The FDA reported the reason for recall as correct labeled product mispack. The product was distributed in KS and the recall is currently ongoing.

Recall Number: D-0597-2025

Reason for Recall
Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL
Initiated
08-05-2025
Reported
09-03-2025
Quantity
10 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Cardinal Health Inc.
Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefilled syringes, Rx Only, Dist. by: Sandoz Inc., Princeton, NJ 08540, Outer package - NDC 55154-3543-5, Inner label - NDC 0781-3238-01

Batch or Lot Expiration Information

Lot# Outer package - NDC 55154-3543-5, Lot SAD08033AA Inner label - NDC 0781-3238-01, Lot SAF13211A